↓ Skip to main content

RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes

Overview of attention for article published in Molecular Cancer, January 2014
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
61 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes
Published in
Molecular Cancer, January 2014
DOI 10.1186/1476-4598-13-27
Pubmed ID
Authors

Katrin K Fleischmann, Philipp Pagel, Irene Schmid, Adelbert A Roscher

Abstract

The translocation t(9;11)(p22;q23) leading to the leukemogenic fusion gene MLL-AF9 is a frequent translocation in infant acute myeloid leukemia (AML). This study aimed to identify genes and molecular processes downstream of MLL-AF9 (alias MLL-MLLT3) which could assist to develop new targeted therapies for such leukemia with unfavorable prognosis.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
India 1 2%
Denmark 1 2%
Canada 1 2%
Unknown 57 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 18 30%
Researcher 14 23%
Student > Master 10 16%
Student > Bachelor 5 8%
Other 4 7%
Other 6 10%
Unknown 4 7%
Readers by discipline Count As %
Agricultural and Biological Sciences 20 33%
Biochemistry, Genetics and Molecular Biology 14 23%
Medicine and Dentistry 9 15%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Computer Science 2 3%
Other 5 8%
Unknown 6 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2014.
All research outputs
#3,062,856
of 4,507,509 outputs
Outputs from Molecular Cancer
#379
of 565 outputs
Outputs of similar age
#84,431
of 127,515 outputs
Outputs of similar age from Molecular Cancer
#26
of 40 outputs
Altmetric has tracked 4,507,509 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 565 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 127,515 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.